GRACE sat down with Dr. Marco Ruiz to discuss "What are the risks and benefits of Ibrutinib and Idelalisib?" for our continuing video series with our Spanish speaking faculty on updates in blood cancer treatments.
Welcome to 2019
Watch for new videos, new articles, new discussions. Thank you for being a part of our story.